What Experts Say About Us - AME Publishing Company

This journal routinely focuses each issue on an important topic in cancer research, and each issue has been an excellent in-depth review of the topic chosen.

Catherine Frenette, MD
Medical Director of Liver Transplantation,
Scripps Center for Organ and Cell Transplantation,
Scripps Green Hospital,
La Jolla, CA, USA

In my interaction with the editorial team, I found the editors to be proactive, professional, and highly efficient in the whole publishing process from an author’s perspective.

Chuan-Yuan Li, PhD
Professor of Dermatology, Pharmacology and Cancer Biology,
Vice Chair for Research, Department of Dermatology,
Duke University Medical Center,
Durham, NC, USA.

This bi-monthly and peer-reviewed publication dedicated to the advancement of clinical translation of cancer research and therapy has become an important resource of new information regarding translational cancer research.

Daohong Zhou, MD
Professor and Deputy Director, Division of Radiation Health,
Department of Pharmaceutical Sciences,
Winthrop P. Rockefeller Endowed Chair for Leukemia Research,
University of Arkansas for Medical Sciences,
Little Rock, AR, USA

I have worked closely with Dr. Chuang in his role as the Editor of Translational Cancer Research. In my scientific and academic opinion, the journal is an outstanding with significant impact in terms of the quality for readership.

David Gius, MD, PhD
Zell Family Scholar Professor,
Department of Radiation Oncology,
Robert H. Lurie Comprehensive Cancer Center,
Northwestern University,
Feinberg School of Medicine,
Vanderbilt Medical School, Nashville, TN, USA

The quality of the journal is outstanding and I believe its form is unique. I have served as a guest editor and reviewers for TCR and I can appreciate the expertise and efficiency of the editorial office.

David J. Chen, PhD
Professor, Division of Molecular Radiation Biology,
Department of Radiation Oncology,
The University of Texas Southwestern Medical Center,
Dallas, Texas, USA

I am convinced due to its unique format and user friendly format it will go from strength to strength and become one of the leading points of reference in our specialty.

Dung-Tsa Chen, PhD
Senior Member, Department of Biostatistics and Bioinformatics,
Moffitt Cancer Center;
Professor, Department of Oncologic Sciences,
University of South Florida, USA